Pharmacovigilance
Pharmacovigilance
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| Arava® -leflunomide | 2019-09-25 | Risk of serious birth defects when administered during pregnancy |
|
| Arava® - leflunomide | 2012-12-23 | Risk of hepatotoxicity Risk of serious birth defects |